Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global Ocular Drug Excipient market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Ocular Drug Excipient is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Ocular Drug Excipient is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Ocular Drug Excipient is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Ocular Drug Excipient include BASF, Beneo, Evonik, Excipact, Fuji Chemical Industries, InVitria, Innophos, JRS Pharma and IOI Oleochemical, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Ocular Drug Excipient production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Ocular Drug Excipient by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Ocular Drug Excipient, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Ocular Drug Excipient, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Ocular Drug Excipient, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ocular Drug Excipient sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Ocular Drug Excipient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Ocular Drug Excipient sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Beneo, Evonik, Excipact, Fuji Chemical Industries, InVitria, Innophos, JRS Pharma and IOI Oleochemical, etc.
By Company
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
Segment by Type
Organic Compounds
Inorganic Compounds
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Ocular Drug Excipient production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Ocular Drug Excipient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Ocular Drug Excipient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ocular Drug Excipient sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Ocular Drug Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Ocular Drug Excipient Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Organic Compounds
1.2.3 Inorganic Compounds
1.3 Market by Application
1.3.1 Global Ocular Drug Excipient Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Manufacturing Organizations (CMOs)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Ocular Drug Excipient Production
2.1 Global Ocular Drug Excipient Production Capacity (2018-2029)
2.2 Global Ocular Drug Excipient Production by Region: 2018 VS 2022 VS 2029
2.3 Global Ocular Drug Excipient Production by Region
2.3.1 Global Ocular Drug Excipient Historic Production by Region (2018-2023)
2.3.2 Global Ocular Drug Excipient Forecasted Production by Region (2024-2029)
2.3.3 Global Ocular Drug Excipient Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Ocular Drug Excipient Revenue Estimates and Forecasts 2018-2029
3.2 Global Ocular Drug Excipient Revenue by Region
3.2.1 Global Ocular Drug Excipient Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Ocular Drug Excipient Revenue by Region (2018-2023)
3.2.3 Global Ocular Drug Excipient Revenue by Region (2024-2029)
3.2.4 Global Ocular Drug Excipient Revenue Market Share by Region (2018-2029)
3.3 Global Ocular Drug Excipient Sales Estimates and Forecasts 2018-2029
3.4 Global Ocular Drug Excipient Sales by Region
3.4.1 Global Ocular Drug Excipient Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Ocular Drug Excipient Sales by Region (2018-2023)
3.4.3 Global Ocular Drug Excipient Sales by Region (2024-2029)
3.4.4 Global Ocular Drug Excipient Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Ocular Drug Excipient Sales by Manufacturers
4.1.1 Global Ocular Drug Excipient Sales by Manufacturers (2018-2023)
4.1.2 Global Ocular Drug Excipient Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocular Drug Excipient in 2022
4.2 Global Ocular Drug Excipient Revenue by Manufacturers
4.2.1 Global Ocular Drug Excipient Revenue by Manufacturers (2018-2023)
4.2.2 Global Ocular Drug Excipient Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Ocular Drug Excipient Revenue in 2022
4.3 Global Ocular Drug Excipient Sales Price by Manufacturers
4.4 Global Key Players of Ocular Drug Excipient, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Ocular Drug Excipient, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Ocular Drug Excipient, Product Offered and Application
4.8 Global Key Manufacturers of Ocular Drug Excipient, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Ocular Drug Excipient Sales by Type
5.1.1 Global Ocular Drug Excipient Historical Sales by Type (2018-2023)
5.1.2 Global Ocular Drug Excipient Forecasted Sales by Type (2024-2029)
5.1.3 Global Ocular Drug Excipient Sales Market Share by Type (2018-2029)
5.2 Global Ocular Drug Excipient Revenue by Type
5.2.1 Global Ocular Drug Excipient Historical Revenue by Type (2018-2023)
5.2.2 Global Ocular Drug Excipient Forecasted Revenue by Type (2024-2029)
5.2.3 Global Ocular Drug Excipient Revenue Market Share by Type (2018-2029)
5.3 Global Ocular Drug Excipient Price by Type
5.3.1 Global Ocular Drug Excipient Price by Type (2018-2023)
5.3.2 Global Ocular Drug Excipient Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Ocular Drug Excipient Sales by Application
6.1.1 Global Ocular Drug Excipient Historical Sales by Application (2018-2023)
6.1.2 Global Ocular Drug Excipient Forecasted Sales by Application (2024-2029)
6.1.3 Global Ocular Drug Excipient Sales Market Share by Application (2018-2029)
6.2 Global Ocular Drug Excipient Revenue by Application
6.2.1 Global Ocular Drug Excipient Historical Revenue by Application (2018-2023)
6.2.2 Global Ocular Drug Excipient Forecasted Revenue by Application (2024-2029)
6.2.3 Global Ocular Drug Excipient Revenue Market Share by Application (2018-2029)
6.3 Global Ocular Drug Excipient Price by Application
6.3.1 Global Ocular Drug Excipient Price by Application (2018-2023)
6.3.2 Global Ocular Drug Excipient Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Ocular Drug Excipient Market Size by Type
7.1.1 US & Canada Ocular Drug Excipient Sales by Type (2018-2029)
7.1.2 US & Canada Ocular Drug Excipient Revenue by Type (2018-2029)
7.2 US & Canada Ocular Drug Excipient Market Size by Application
7.2.1 US & Canada Ocular Drug Excipient Sales by Application (2018-2029)
7.2.2 US & Canada Ocular Drug Excipient Revenue by Application (2018-2029)
7.3 US & Canada Ocular Drug Excipient Sales by Country
7.3.1 US & Canada Ocular Drug Excipient Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Ocular Drug Excipient Sales by Country (2018-2029)
7.3.3 US & Canada Ocular Drug Excipient Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Ocular Drug Excipient Market Size by Type
8.1.1 Europe Ocular Drug Excipient Sales by Type (2018-2029)
8.1.2 Europe Ocular Drug Excipient Revenue by Type (2018-2029)
8.2 Europe Ocular Drug Excipient Market Size by Application
8.2.1 Europe Ocular Drug Excipient Sales by Application (2018-2029)
8.2.2 Europe Ocular Drug Excipient Revenue by Application (2018-2029)
8.3 Europe Ocular Drug Excipient Sales by Country
8.3.1 Europe Ocular Drug Excipient Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Ocular Drug Excipient Sales by Country (2018-2029)
8.3.3 Europe Ocular Drug Excipient Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Ocular Drug Excipient Market Size by Type
9.1.1 China Ocular Drug Excipient Sales by Type (2018-2029)
9.1.2 China Ocular Drug Excipient Revenue by Type (2018-2029)
9.2 China Ocular Drug Excipient Market Size by Application
9.2.1 China Ocular Drug Excipient Sales by Application (2018-2029)
9.2.2 China Ocular Drug Excipient Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Ocular Drug Excipient Market Size by Type
10.1.1 Asia Ocular Drug Excipient Sales by Type (2018-2029)
10.1.2 Asia Ocular Drug Excipient Revenue by Type (2018-2029)
10.2 Asia Ocular Drug Excipient Market Size by Application
10.2.1 Asia Ocular Drug Excipient Sales by Application (2018-2029)
10.2.2 Asia Ocular Drug Excipient Revenue by Application (2018-2029)
10.3 Asia Ocular Drug Excipient Sales by Region
10.3.1 Asia Ocular Drug Excipient Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Ocular Drug Excipient Revenue by Region (2018-2029)
10.3.3 Asia Ocular Drug Excipient Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Ocular Drug Excipient Market Size by Type
11.1.1 Middle East, Africa and Latin America Ocular Drug Excipient Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Ocular Drug Excipient Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Ocular Drug Excipient Market Size by Application
11.2.1 Middle East, Africa and Latin America Ocular Drug Excipient Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Ocular Drug Excipient Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Ocular Drug Excipient Sales by Country
11.3.1 Middle East, Africa and Latin America Ocular Drug Excipient Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Ocular Drug Excipient Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Ocular Drug Excipient Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Overview
12.1.3 BASF Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 BASF Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 Beneo
12.2.1 Beneo Company Information
12.2.2 Beneo Overview
12.2.3 Beneo Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Beneo Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Beneo Recent Developments
12.3 Evonik
12.3.1 Evonik Company Information
12.3.2 Evonik Overview
12.3.3 Evonik Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Evonik Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Evonik Recent Developments
12.4 Excipact
12.4.1 Excipact Company Information
12.4.2 Excipact Overview
12.4.3 Excipact Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Excipact Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Excipact Recent Developments
12.5 Fuji Chemical Industries
12.5.1 Fuji Chemical Industries Company Information
12.5.2 Fuji Chemical Industries Overview
12.5.3 Fuji Chemical Industries Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Fuji Chemical Industries Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Fuji Chemical Industries Recent Developments
12.6 InVitria
12.6.1 InVitria Company Information
12.6.2 InVitria Overview
12.6.3 InVitria Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 InVitria Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 InVitria Recent Developments
12.7 Innophos
12.7.1 Innophos Company Information
12.7.2 Innophos Overview
12.7.3 Innophos Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Innophos Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Innophos Recent Developments
12.8 JRS Pharma
12.8.1 JRS Pharma Company Information
12.8.2 JRS Pharma Overview
12.8.3 JRS Pharma Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 JRS Pharma Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 JRS Pharma Recent Developments
12.9 IOI Oleochemical
12.9.1 IOI Oleochemical Company Information
12.9.2 IOI Oleochemical Overview
12.9.3 IOI Oleochemical Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 IOI Oleochemical Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 IOI Oleochemical Recent Developments
12.10 Millipore Sigma
12.10.1 Millipore Sigma Company Information
12.10.2 Millipore Sigma Overview
12.10.3 Millipore Sigma Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Millipore Sigma Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Millipore Sigma Recent Developments
12.11 Mallinckrodt Pharmaceuticals
12.11.1 Mallinckrodt Pharmaceuticals Company Information
12.11.2 Mallinckrodt Pharmaceuticals Overview
12.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Mallinckrodt Pharmaceuticals Recent Developments
12.12 Pfanstiehl
12.12.1 Pfanstiehl Company Information
12.12.2 Pfanstiehl Overview
12.12.3 Pfanstiehl Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 Pfanstiehl Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Pfanstiehl Recent Developments
12.13 PerkinElmer
12.13.1 PerkinElmer Company Information
12.13.2 PerkinElmer Overview
12.13.3 PerkinElmer Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 PerkinElmer Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 PerkinElmer Recent Developments
12.14 Natoli
12.14.1 Natoli Company Information
12.14.2 Natoli Overview
12.14.3 Natoli Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Natoli Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Natoli Recent Developments
12.15 DFE Pharma
12.15.1 DFE Pharma Company Information
12.15.2 DFE Pharma Overview
12.15.3 DFE Pharma Ocular Drug Excipient Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.15.4 DFE Pharma Ocular Drug Excipient Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 DFE Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ocular Drug Excipient Industry Chain Analysis
13.2 Ocular Drug Excipient Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ocular Drug Excipient Production Mode & Process
13.4 Ocular Drug Excipient Sales and Marketing
13.4.1 Ocular Drug Excipient Sales Channels
13.4.2 Ocular Drug Excipient Distributors
13.5 Ocular Drug Excipient Customers
14 Ocular Drug Excipient Market Dynamics
14.1 Ocular Drug Excipient Industry Trends
14.2 Ocular Drug Excipient Market Drivers
14.3 Ocular Drug Excipient Market Challenges
14.4 Ocular Drug Excipient Market Restraints
15 Key Finding in The Global Ocular Drug Excipient Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
听
听
*If Applicable.
